Covered recipient · General Payments record
JENNY MCDADE DESPOTOVIC
Allopathic & Osteopathic Physicians Pediatrics Pediatric Hematology-Oncology
General Payments · PY2019–2022
$58,898.30
- Reported across 37 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2022 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $11,300.00 | 5 |
| Honoraria | $5,408.75 | 3 |
| Food and Beverage | $288.92 | 4 |
By paying entity
PY2022 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Agios Pharmaceuticals, Inc. | $5,678.73 | 6 |
| Apellis Pharmaceuticals, Inc. | $5,400.00 | 3 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $3,125.00 | 1 |
| SOBI, INC | $2,775.00 | 1 |
| Amgen Inc. | $18.94 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2022 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Agios Pharmaceuticals, Inc. | $971.25 | 03/04/2022 | Honoraria | Undisputed | 01/23/2026 | 953522565 | CMS |
| Agios Pharmaceuticals, Inc. | $27.45 | 04/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 953522927 | CMS |
| Agios Pharmaceuticals, Inc. | $1,942.50 | 06/30/2022 | Honoraria | Undisputed | 01/23/2026 | 953518163 | CMS |
| Agios Pharmaceuticals, Inc. | $125.00 | 07/20/2022 | Food and Beverage | Undisputed | 01/23/2026 | 953521925 | CMS |
| Agios Pharmaceuticals, Inc. | $2,495.00 | 07/20/2022 | Honoraria | Undisputed | 01/23/2026 | 953523243 | CMS |
| Agios Pharmaceuticals, Inc. | $117.53 | 08/17/2022 | Food and Beverage | Undisputed | 01/23/2026 | 953520217 | CMS |
| Amgen Inc. | $18.94 | 12/22/2022 | Food and Beverage | Undisputed | 01/23/2026 | 939278455 | CMS |
| Apellis Pharmaceuticals, Inc. | $1,800.00 | 01/21/2022 | Consulting Fee | Undisputed | 01/23/2026 | 964254445 | CMS |
| Apellis Pharmaceuticals, Inc. | $1,800.00 | 05/09/2022 | Consulting Fee | Undisputed | 01/23/2026 | 964255165 | CMS |
| Apellis Pharmaceuticals, Inc. | $1,800.00 | 09/09/2022 | Consulting Fee | Undisputed | 01/23/2026 | 964257005 | CMS |
| Novartis Pharmaceuticals Corporation | $3,125.00 | 06/07/2022 | Consulting Fee | Undisputed | 01/23/2026 | 893600815 | CMS |
| SOBI, INC | $2,775.00 | 06/14/2022 | Consulting Fee | Undisputed | 01/23/2026 | 964385329 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2020, 2021, 2022
- Generated from
- OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.